Sign in Subscribe
COVID-19 vaccines

Filipinos Prefer US-Made Vaccines, SWS Survey Reveals

Strategic Insights

— 1 min read

A recent survey conducted by Social Weather Stations (SWS) has shown that six out of ten Filipinos prefer vaccines made in the United States, with 63% of respondents expressing a desire to receive US-made vaccine shots. The survey, which involved 1,200 respondents, also highlighted the top five preferred countries of vaccine origin among Filipinos, with the US, China, Japan, Australia, and the United Kingdom being the top choices.

Key Takeaways:

  • 63% of Filipinos prefer US-made vaccines, according to the SWS survey, which involved 1,200 respondents.
  • The top five preferred countries of vaccine origin among Filipinos are the US, China, Japan, Australia, and the United Kingdom.
  • In terms of brand preference, 39% of Filipinos would agree to get injected with Coronavac, the vaccine made by China's Sinovac BioNTech, while 33% preferred Pfizer-BioNTech, and 22% selected Oxford-AstraZeneca.
  • 74% of US residents in a separate survey conducted by M Booth Health and Savanta had a preferred vaccine brand, with 36% preferring Pfizer, 19% favoring Moderna, and 17% choosing Johnson and Johnson.
  • Vaccine brand preference among US residents was influenced by factors such as vaccine efficacy, positive study data, and fewer side effects and safety concerns.
  • Positive news reports and social media posts are likely influencing factors in vaccine brand preference, with 57% of US residents citing these factors as playing a role in their decision.

Statistics:

  • 63% of Filipinos prefer US-made vaccines, according to the SWS survey.
  • 1,200 respondents participated in the SWS survey.
  • 39% of Filipinos would agree to get injected with Coronavac, while 63% prefer US-made vaccines.
  • 74% of US residents have a preferred vaccine brand, according to the M Booth Health and Savanta survey.
  • 36% of US residents prefer Pfizer, 19% favor Moderna, and 17% choose Johnson and Johnson.
  • 57% of US residents were influenced by positive news reports and social media posts in their vaccine brand preference.
  • 3.009 million doses of AstraZeneca vaccine have been purchased as of March 2021, while Pfizer-BionTech has sold 1.220 million doses of BNT162b2 mRNA vaccines.
  • 1.404 million doses of NVX-CoV2373 vaccines made by Novavax have been sold as of March 2021.

Sources:

  • Social Weather Stations (SWS) survey
  • M Booth Health and Savanta survey
  • Our World in Data (OWID)
  • Statista
  • Department of Health (DOH)
  • Commission on Human Rights (CHR)
  • World Health Organization (WHO)

Read more